Impax Asset Management Group PLC Pacira Bio Sciences, Inc. Transaction History
Impax Asset Management Group PLC
- $19.8 Billion
- Q4 2024
A detailed history of Impax Asset Management Group PLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Impax Asset Management Group PLC holds 540,027 shares of PCRX stock, worth $11.9 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
540,027
Previous 470,603
14.75%
Holding current value
$11.9 Million
Previous $7.09 Million
43.56%
% of portfolio
0.05%
Previous 0.03%
Shares
11 transactions
Others Institutions Holding PCRX
# of Institutions
260Shares Held
49.8MCall Options Held
1.03MPut Options Held
139K-
Black Rock Inc. New York, NY8.01MShares$176 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.26MShares$116 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA3.26MShares$71.9 Million0.15% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.26MShares$49.8 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.99MShares$43.9 Million0.06% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.01B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...